BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago
ADVERTISEMENT
AlphaGraphs

Infographic: CME Group Q4 adj. profit jumps on strong revenue growth

CME Group Inc. (NASDAQ: CME), which operates a derivatives exchange, on Wednesday reported a double-digit increase in adjusted profit for the fourth quarter of 2023. Earnings benefited from a 19% revenue growth. Net income, excluding special items, increased an impressive 23% year-over-year to $2.37 per share in the December quarter from $1.92 per share in the […]

February 14, 2024 1 min read

CME Group Inc. (NASDAQ: CME), which operates a derivatives exchange, on Wednesday reported a double-digit increase in adjusted profit for the fourth quarter of 2023. Earnings benefited from a 19% revenue growth.

CME Group Q4 2023 earnings infographic

Net income, excluding special items, increased an impressive 23% year-over-year to $2.37 per share in the December quarter from $1.92 per share in the corresponding period of 2022. Unadjusted profit moved up to $804.3 million or $2.24 per share in the fourth quarter from $629.9 million or $1.75 per share in the prior-year quarter.

The bottom line benefited from a 19% increase in revenues to $1.44 billion during the three months. Average daily volume increased to 25.5 million in Q4 from 21.8 million a year earlier.

ADVERTISEMENT
ADVERTISEMENT